News Discover the latest news stories, blog posts and publications from Cobra's expert team. You are here: Home News Toggle filters Year: All Years 2018 2017 2016 2015 2014 2013 2012 2011 or Month: All Months January February March April May June July August September October November December or Type: All Categories DNA Fill Finish General Proteins Technologies Viral Vectors Showing posts in the tag 'expansion'. Show all posts Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant DNA, Gene Therapy, Viral Vectors Funding will be used to develop world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK Gene Therapy, News Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK 2017 Highlights News What a year 2017 turned out to be! With a 50% increase in contracts compared to 2016 it has been a very busy year recruiting and expanding the facilities to meet customer deadlines... Take a Look Around Our New Website General We are delighted to announce that our brand new and improved website at cobrabio.com has now gone live! Cobra Expansion Video Blog DNA, Gene Therapy, Viral Vectors As We Embark On A £15m / 165m SEK / $19m Gene Therapy Manufacturing Operations Expansion Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion DNA, Gene Therapy, Viral Vectors Capacity increase in response to customer demand for DNA and viral vector production Cobra expanderar på CDMO-marknaden för biologiska läkemedel General Artikel i Läkemedelsmarknaden: Cobra expands on the CDMO-market for biological drugs
Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant DNA, Gene Therapy, Viral Vectors Funding will be used to develop world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK Gene Therapy, News Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK
2017 Highlights News What a year 2017 turned out to be! With a 50% increase in contracts compared to 2016 it has been a very busy year recruiting and expanding the facilities to meet customer deadlines...
Take a Look Around Our New Website General We are delighted to announce that our brand new and improved website at cobrabio.com has now gone live!
Cobra Expansion Video Blog DNA, Gene Therapy, Viral Vectors As We Embark On A £15m / 165m SEK / $19m Gene Therapy Manufacturing Operations Expansion
Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion DNA, Gene Therapy, Viral Vectors Capacity increase in response to customer demand for DNA and viral vector production
Cobra expanderar på CDMO-marknaden för biologiska läkemedel General Artikel i Läkemedelsmarknaden: Cobra expands on the CDMO-market for biological drugs